RIA
UTHR icon

Retirement Investment Advisors’s United Therapeutics UTHR Stock Holding History

Retirement Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Hold
600
– – 0.02% 50
2026
Q1 		$292K Hold
600
– – 0.02% 50
2025
Q4 		$292K Hold
600
– – 0.02% 50
2025
Q3 		$252K Buy
+600
New +$202K 0.02% 53
2025
Q1 		– Sell
-600
Closed -$212K – 61
2024
Q4 		$212K Hold
600
– – 0.02% 55
2024
Q3 		$215K Buy
+600
New +$203K 0.02% 50
2023
Q4 		– Sell
-1,200
Closed -$271K – 63
2023
Q3 		$271K Hold
1,200
– – 0.02% 52
2023
Q2 		$265K Buy
+1,200
New +$266K 0.03% 54

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Retirement Investment Advisors's UTHR Position: Q2 2026 in Review

Retirement Investment Advisors held its United Therapeutics (UTHR) position steady in Q2 2026 at 600 shares worth $321K. The position accounts for 0.02% of the portfolio, ranked #50.

Retirement Investment Advisors first reported a position in UTHR in Q2 2023 and has held it in 8 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Retirement Investment Advisors held 600 shares of United Therapeutics worth $321K as of Q2 2026.
  • Retirement Investment Advisors left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.02% of Retirement Investment Advisors's portfolio in Q2 2026, its #50 holding.
  • Retirement Investment Advisors first reported a position in United Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Retirement Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.